“It is fair to say ........ that Dr. Kovar acknowledged that his wide range of twenty five to thirty five came from Professor Strauss’s published work, that his own particular input was to place B at the bottom of the range, and that – I quote Dr. Kovar’s oral evidence – “If a court came to the conclusion that the right range was Strauss’s twenty two to twenty five I would be at the lower end of that. I would have to move down.”
“Those criticisms ........ are in my judgment sufficient to demonstrate that it would be wrong, at least in this case, to depart from the conventional manner of determining life expectancy. This is done by reference to general life tables in the ordinary run of cases and on the basis of medical evidence in the special type of case like B’s. I accept that statistics are a useful tool in the hand of the clinician but where reliable medical evidence is before the court they should not displace the expertise of the clinician. They provide, rather, a useful background to, and cross-check on, the work of the doctor.”
“I understand Professor Strauss is of the view that this approach is flawed. (He has the benefit of the original data). He calculates B’s life expectancy (defined as average number of remaining years of life of the cohort of individuals with that age and condition) as 14·9 additional years, that is to the age of 22·2 years. He argues that this value is more appropriate for the court to consider than “median”
“Experience does recognise that survival into adulthood is not uncommon. There is a view in the UK that reliance on the combined Strauss data over-estimates life expectancy. B’s disabilities moreover are more marked than most in the high LAS group in Hutton. In order to arrive at a balanced opinion on which to advise the court my opinion in this case is based on - my assessment of the severity of B’s disabilities and the positive and negative factors discussed above. - my understanding of the published data pointing to survival into adult life of children like B whilst recognising the question marks around this data as discussed above, seeing the dedicated care she receives at home, - my experience over years of similar children now young adults in their twenties, but equally of several apparently well CP children – adolescents who were disabled as B is now who later died in childhood or in their teens from intercurrent infection, or suddenly and unexplained, with incidental illness, or in association with a seizure (epilepsy), and - taking account of various colleagues views on prognosis and life expectancy in similar cases of children both similarly and worse affected than B, - applying my own clinical intuition and judgment.”
“A limitation of the life expectancy and survival analysis reported here. ...... and in other studies is that they are based on only a crude classification of functional level. More appropriate estimates of life expectancy and survival probabilities for a subject with a given profile of age, gender, functional skills, etc. may be obtained using the methods described here.”
“I accept that statistics are a useful tool in the hand of the clinician but where reliable medical evidence is before the court, they should not displace the expertise of the clinician. They provide, rather, a useful background to, and cross-check on, the work of the doctor.”
“The first orthodoxy or convention is that where the life expectancy of a claimant is in issue, it is most appropriately determined on the basis of medical evidence. In this case, it is said, interrogation of a data-base which contains the history of patients whose condition is similar to B’s will provide an answer to the question – ‘what is her life expectancy?’ which is more likely to be accurate than anything coming from the doctors who have seen her.”
“.... It would be wrong, at least in this case, to depart from the conventional manner of determining life expectancy. This is done by reference to general life tables in the ordinary run of cases and on the basis of medical evidence in the special type of case like B’s.”
“Precise attempts at precise calculations in life expectancy is not part of my daily work.”
“Well, I have been doing it for medico-legal purposes for a few years and it is not at all straightforward, and this case brought home to me even more than that – it brought home to me even more. It’s a very complex matter. I think everyone finds it complex, difficult and imprecise.”
“I have to confess to having found the evidence of Dr Strauss, whether written or oral, extremely difficult to follow.”
“Dr Lloyd seemed to me to be attempting to fit B into or around the Strauss figures which had for him become rather too much of a straight jacket. Dr Kovar, on the other hand, brought to the case what I have described as a holistic approach. He said that he put into the equation – and I accept his evidence as to this – his examination of B, the published information, his own clinical judgment, his experience and the views of colleagues. To me that is an approach which inspires confidence.”
“Suppose the court came to the view, apparently supported by Dr Lloyd, that certainly subject to the question of moving it one way or the other, that the proper range is Professor Strauss’ 22-25? A – I would be closer to 22 than 25, because I believe B is in the worst category of Professor Strauss’ database, and I then throw in the add-on which is things such as the Baclofen Pump, the pepper and salt, so I would move down. I have used that range from Professor Strauss’ data. I am told that that was quite inappropriate that this should be the range, on the strength of his data, and logically I move down in relation to that as well.”